American Bio Medica Corporation (ABMC)
OTCMKTS: ABMC · Delayed Price · USD
0.0003
0.00 (0.00%)
Apr 15, 2024, 9:30 AM EDT - Market open
American Bio Medica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.91 | 2.22 | 4.15 | 3.66 | 3.87 | 4.91 | 5.61 | 6.32 | 7.29 | 8.89 | Upgrade
|
| Revenue Growth (YoY) | -58.84% | -46.52% | 13.46% | -5.60% | -21.20% | -12.39% | -11.21% | -13.29% | -18.09% | -4.81% | Upgrade
|
| Cost of Revenue | 1.11 | 1.67 | 2.91 | 2.47 | 2.58 | 2.92 | 3.12 | 3.46 | 4.22 | 5.32 | Upgrade
|
| Gross Profit | -0.19 | 0.55 | 1.24 | 1.18 | 1.29 | 2 | 2.49 | 2.86 | 3.06 | 3.57 | Upgrade
|
| Selling, General & Admin | 1.05 | 1.64 | 1.77 | 1.7 | 1.96 | 2.19 | 2.56 | 2.93 | 3.05 | 4.06 | Upgrade
|
| Research & Development | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 | 0.12 | 0.18 | 0.15 | 0.23 | 0.65 | Upgrade
|
| Other Operating Expenses | 0.03 | 0.68 | -0.17 | -0.09 | -0.26 | 0.04 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 1.14 | 1.73 | 1.86 | 1.78 | 2.05 | 2.31 | 2.75 | 3.08 | 3.28 | 4.7 | Upgrade
|
| Operating Income | -1.24 | -1.18 | -0.62 | -0.59 | -0.76 | -0.31 | -0.26 | -0.23 | -0.22 | -1.13 | Upgrade
|
| Interest Income | 0 | 0.19 | 0.18 | 0.27 | 0 | 0 | 0 | -0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.19 | 0.19 | 0.18 | 0.27 | 0.28 | 0.27 | 0.28 | 0.21 | 0.24 | 0.31 | Upgrade
|
| Other Expense / Income | -0.03 | -0.72 | 0.17 | 0.09 | -0.02 | -0.27 | -0.2 | -0.1 | 0.03 | -0.65 | Upgrade
|
| Pretax Income | -1.41 | -0.46 | -0.79 | -0.69 | -1.03 | -0.55 | -0.34 | -0.33 | -0.49 | -0.79 | Upgrade
|
| Income Tax | 0 | 0 | 0 | -0.01 | 0 | 0.23 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income | -1.41 | -0.46 | -0.8 | -0.68 | -1.03 | -0.55 | -0.35 | -0.33 | -0.49 | -0.79 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 43 | 36 | 33 | 30 | 29 | 27 | 26 | 23 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 43 | 36 | 33 | 30 | 29 | 27 | 26 | 23 | 22 | Upgrade
|
| Shares Change | 12.29% | 20.26% | 9.32% | 8.01% | 3.09% | 6.37% | 6.96% | 10.03% | 4.79% | 2.00% | Upgrade
|
| EPS (Basic) | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 | Upgrade
|
| Free Cash Flow | -0.77 | -0.67 | -0.49 | 0.06 | -0.24 | 0.12 | 0.21 | 0.21 | 0.02 | -0.03 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.01 | 0.00 | -0.01 | 0.00 | 0.01 | 0.01 | 0.00 | -0.00 | Upgrade
|
| Gross Margin | -21.14% | 24.71% | 29.85% | 32.39% | 33.26% | 40.64% | 44.39% | 45.20% | 42.03% | 40.16% | Upgrade
|
| Operating Margin | -136.04% | -53.16% | -14.97% | -16.22% | -19.68% | -6.33% | -4.58% | -3.58% | -2.98% | -12.72% | Upgrade
|
| Profit Margin | -154.44% | -20.87% | -19.19% | -18.63% | -26.55% | -11.09% | -6.15% | -5.27% | -6.73% | -8.86% | Upgrade
|
| Free Cash Flow Margin | -84.12% | -30.34% | -11.74% | 1.59% | -6.25% | 2.38% | 3.76% | 3.31% | 0.32% | -0.28% | Upgrade
|
| EBITDA | -1.16 | -0.43 | -0.62 | -0.59 | -0.76 | -0.19 | -0.17 | -0.14 | -0.11 | -1.01 | Upgrade
|
| EBITDA Margin | -127.38% | -19.57% | -14.97% | -16.22% | -19.68% | -3.93% | -2.96% | -2.15% | -1.46% | -11.39% | Upgrade
|
| Depreciation & Amortization | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.11 | 0.12 | Upgrade
|
| EBIT | -1.21 | -0.5 | -0.7 | -0.67 | -0.84 | -0.27 | -0.26 | -0.23 | -0.22 | -1.13 | Upgrade
|
| EBIT Margin | -132.97% | -22.63% | -16.88% | -18.44% | -21.77% | -5.56% | -4.58% | -3.59% | -2.98% | -12.69% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.